Burning Rock Biotech Limi...
6.55
0.09 (1.39%)
At close: Jan 13, 2025, 9:00 PM
6.50
-0.76%
After-hours Jan 14, 2025, 05:09 PM EST
undefined%
Bid 6.5
Market Cap 72.39M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -5.67
PE Ratio (ttm) -1.16
Forward PE n/a
Analyst n/a
Ask 7.4
Volume 28,628
Avg. Volume (20D) 20,436
Open 6.72
Previous Close 6.46
Day's Range 6.24 - 6.79
52-Week Range 2.62 - 9.80
Beta undefined

About BNR

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestina...

Sector Healthcare
IPO Date Jun 12, 2020
Employees 786
Stock Exchange NASDAQ
Ticker Symbol BNR
1 month ago · Source
+13.61%
Burning Rock Biotech shares are trading higher aft... Unlock content with Pro Subscription
3 months ago · Source
-4.13%
Burning Rock Biotech shares are trading lower. The company announced the resignation of its director and CFO.